Please login to the form below

Not currently logged in
Email:
Password:

Oragenics

This page shows the latest Oragenics news and features for those working in and with pharma, biotech and healthcare.

Meeting with resistance

Oragenics believes that large-scale, cost-effective production of clinical grade MU1140-S will be possible by use of DPOLTTM. ... It appears unlikely that NAI-107 is as far advanced in development as Oragenics' MU1140-S.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Alan Joslyn becomes president and CEO of Oragenics Dr Alan Joslyn becomes president and CEO of Oragenics

    He will also serve on the company’s board of directors. Florida-based Oragenics has appointed Dr Alan Joslyn as its new president, chief executive officer and member of the board ... We believe that his passion for technology will help ensure that

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics